CAS:790299-79-5
Molecular Formula:C28H30N6OS
Molecular Weight:498.64
EINECS:226-164-5
Synonyms:MASITINIB; Masatinib; Masivet; MASITINIB 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[4-Methyl-3-[[4-(3-pyridinyl)-2-; thiazolyl]aMino]phenyl]benzaMide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide Masitinib; (AB1010); masitinib API
Masitinib is a tyrosine kinase inhibitor. Its clinical indications include amyotrophic lateral sclerosis, mastocytosis, pancreatic cancer, multiple sclerosis, asthma, prostate cancer, etc.
| Item | Specification |
| MW | 498.64 |
| Density | 1.280±0.06 g/cm3(Predicted) |
| EINECS | 226-164-5 |
| pKa | 13.24±0.70(Predicted) |
| Melting point | 90-95°C |
| Storage conditions | Refrigerator |
Masitinib， Also known as mesatinib mesylate, it is a platelet-derived growth factor alpha/beta receptor tyrosine kinase inhibitor developed by AB Science for the treatment of multiple myeloma, gastrointestinal stromal tumors, and prostate cancer.
Usually packed in 25kg/drum,and also can be do customized package.
EN 
ZH 
DE 
ES 
KO 
PT 
FR 
TH 
AR 
IT 
VI 
NL 
RU 
